EPSTEIN-BARR VIRUS EARLY RNA EBER-ISH IN-SITU-HYBRIDIZATION Test
Test Name: EPSTEIN-BARR VIRUS EARLY RNA EBER-ISH IN-SITU-HYBRIDIZATION Test
Components: Price: 970.0 AED
Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathologyreport, Site of biopsy and Clinical history.
Report Delivery: 10-12 days
Method: In-Situ-Hybridization
Test type: Cancer
Doctor: Oncologist
Test Department:
Pre Test Information: Provide a copy of the Histopathologyreport, Site of biopsy and Clinical history.
Test Details
The Epstein-Barr Virus Early RNA (EBER-ISH) In-Situ-Hybridization test is a laboratory technique used to detect the presence of Epstein-Barr virus (EBV) in tissues or cells. Epstein-Barr virus is a common virus that infects most people at some point in their lives. It is associated with various diseases, including infectious mononucleosis, certain types of cancer (such as Burkitt’s lymphoma and nasopharyngeal carcinoma), and autoimmune disorders.
The EBER-ISH test uses specific probes that bind to the early RNA molecules produced by the Epstein-Barr virus during its replication cycle. These probes are labeled with a detectable marker, such as a fluorescent dye or an enzyme, which allows visualization of the virus in the tissue or cells under a microscope. During the test, tissue samples or cells are collected and fixed onto slides. The EBER probes are then applied to the slides and allowed to hybridize (bind) to the viral RNA if it is present. After washing off any unbound probes, the slides are examined under a microscope to detect the presence of the labeled probes, indicating the presence of Epstein-Barr virus.
The EBER-ISH test is highly sensitive and specific for detecting Epstein-Barr virus, even at low levels. It is particularly useful in diagnosing Epstein-Barr virus-associated malignancies, as well as monitoring the effectiveness of treatment in these cases. Overall, the EBER-ISH test plays a crucial role in the diagnosis and management of Epstein-Barr virus-related diseases.
Test Name | EPSTEIN-BARR VIRUS EARLY RNA EBER-ISH IN-SITU-HYBRIDIZATION Test |
---|---|
Components | |
Price | 970.0 AED |
Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathologyreport, Site of biopsy and Clinical history. |
Report Delivery | 10-12 days |
Method | In-Situ-Hybridization |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | |
Pre Test Information | Provide a copy of the Histopathologyreport, Site of biopsy and Clinical history. |
Test Details | The Epstein-Barr Virus Early RNA (EBER-ISH) In-Situ-Hybridization test is a laboratory technique used to detect the presence of Epstein-Barr virus (EBV) in tissues or cells. Epstein-Barr virus is a common virus that infects most people at some point in their lives. It is associated with various diseases, including infectious mononucleosis, certain types of cancer (such as Burkitt’s lymphoma and nasopharyngeal carcinoma), and autoimmune disorders. The EBER-ISH test uses specific probes that bind to the early RNA molecules produced by the Epstein-Barr virus during its replication cycle. These probes are labeled with a detectable marker, such as a fluorescent dye or an enzyme, which allows visualization of the virus in the tissue or cells under a microscope. During the test, tissue samples or cells are collected and fixed onto slides. The EBER probes are then applied to the slides and allowed to hybridize (bind) to the viral RNA if it is present. After washing off any unbound probes, the slides are examined under a microscope to detect the presence of the labeled probes, indicating the presence of Epstein-Barr virus. The EBER-ISH test is highly sensitive and specific for detecting Epstein-Barr virus, even at low levels. It is particularly useful in diagnosing Epstein-Barr virus-associated malignancies, as well as monitoring the effectiveness of treatment in these cases. Overall, the EBER-ISH test plays a crucial role in the diagnosis and management of Epstein-Barr virus-related diseases. |